← All indications
Endometriosis
A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
Drugs by status
Approved for this indication (9)
Phase 4 trials (34)
- simvastatin
- metronidazole
- propofol
- vitamin d3
- norgestrel
- tibolone
- calcium carbonate
- ketamine
- estetrol
- ethinyl estradiol
- goserelin
- indocyanine green
- drospirenone
- desogestrel
- atorvastatin
- rocuronium
- acetylsalicylic acid
- bupivacaine
- anastrozole
- resveratrol
- clonidine
- ulipristal
- xuefu zhuyu
- medroxyprogesterone
- triptorelin
- neostigmine
- bazedoxifene
- gestodene
- chlormadinone
- honghua
- +4 more
Phase 3 trials (23)
Phase 2 trials (48)
- metformin
- melatonin
- ringer's lactate
- Opigolix
- afatinib
- axitinib
- vitamin e
- asoprisnil
- bay1128688
- Eliapixant
- zk811752
- raloxifene
- dr-2001
- prinaberel
- fluoroestradiol
- Filgrastim
- bgs649
- tanezumab
- platelet-rich plasma
- cabergoline
- dronabinol
- rimabotulinumtoxinB
- vitamin c
- cetrorelix
- abt-869
- Atosiban
- lidocaine
- quinagolide
- progenta
- tetrahydrocannabinol
- +18 more
Phase 1 trials (20)
Other trials (25)
- mannitol
- ketoprofen
- diphenhydramine
- sodium dichloroacetate
- ferrous fumarate
- palmitoylethanolamide
- gabapentin
- gemcitabine
- paclitaxel
- ganirelix
- lactulose
- ropivacaine
- acetaminophen
- pomegranate
- pravastatin
- fluorescein
- tramadol
- apple
- curcuma longa
- pregabalin
- clomifene
- quercetin
- d-chiro-inositol
- lactobacillus
- human choriogonadotropin alfa
Organizations
Organization Involved with Phase 4 Indications (45)
- Merck
- Ipsen
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Ain Shams University
- AZ Jan Palfijn Gent
- Chulalongkorn University
- China Academy of Chinese Medical Sciences
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Harvard University
- Federal University of Rio Grande do Sul
- Kocaeli University
- Northwestern University
- Onze Lieve Vrouw Hospital
- Sheffield Hallam University
- University of Louisville
- University of Milan
- University of Athens
- University of Valencia
- University of Versailles
- Capital Medical University
- Colorado Center for Reproductive Medicine
- Istanbul University
- Prince of Songkla University
- Stony Brook University
- Suleymaniye Birth And Women's Health Education And Research Hospital
- University of Cagliari
- University of Chicago
- +15 more
Organization Involved with Phase 3 Indications (25)
- Myovant Sciences GmbH
- ObsEva SA
- Omrix Biopharmaceuticals, Inc.
- Dexa Medica Group
- Nobel Pharmaceuticals
- Fundación Santa Fe de Bogota
- Cairo University
- Centre Hospitalier Universitaire de la Réunion
- Mediterranea Medica S. L.
- University of Michigan
- University of Rochester
- Yale University
- University of Colorado, Denver
- Taipei Veteran General hospital
- University of Indonesia
- American University of Beirut
- Medical Clinic Mediterranea
- Pennsylvania State University
- State University of New York, Brooklyn
- University of Barcelona
- University of North Carolina at Chapel Hill
- Nissay Hospital, Osaka
- University of Wisconsin
- Rouen Normandy University
- ASKA Pharmaceutical Co., Ltd.
Organization Involved with Phase 2 Indications (46)
- Abbott
- Lumara Health
- Takeda
- Astellas
- Jenapharm
- Pfizer
- Wyeth
- Novartis
- Hengrui Therapeutics, Inc.
- Immunitor LLC
- Kissei Pharmaceuticals
- Duramed Research
- Enteris BioPharma Inc.
- Isifer AB
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Neurological Disorders and Stroke (NINDS)
- Ajou University
- Danderyds Hospital
- Duke University
- Katholieke Universiteit Leuven
- Korea University
- Kyung Hee University
- Mahidol University
- Oregon College of Oriental Medicine
- Oregon Health and Science University
- Seoul National University
- Stanford University
- Wake Forest University
- Mayo Clinic
- Chinese University of Hong Kong
- +16 more
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (25)
- Indiana University
- Mansoura University
- Toronto Centre for Advanced Reproductive Technology
- University of Edinburgh
- University of Ioannina
- University of Nottingham
- University of Oklahoma
- University of Patras
- University of Toronto
- University of Birmingham
- University of Bologna
- Kanuni Sultan Suleyman Training and Research Hospital
- Poznan University
- Tel Aviv University
- University of California, Davis
- Medical University of Vienna
- Tottori University
- University Hospital, Rijeka
- Technion University
- University of Tennessee, Chattanooga
- Biomet
- National Research Center, Egypt
- Lebanese University
- Sheba Medical Center
- General Hospital Pula